Systematic Financial Management LP Raises Stake in Natus Medical Incorporated (BABY)
Systematic Financial Management LP raised its holdings in shares of Natus Medical Incorporated (NASDAQ:BABY) by 4.3% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 45,989 shares of the medical equipment provider’s stock after acquiring an additional 1,900 shares during the quarter. Systematic Financial Management LP owned approximately 0.14% of Natus Medical worth $1,715,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also modified their holdings of the company. BlackRock Inc. grew its stake in shares of Natus Medical by 137,510.8% during the 1st quarter. BlackRock Inc. now owns 4,124,195 shares of the medical equipment provider’s stock worth $161,874,000 after acquiring an additional 4,121,198 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Natus Medical by 4.8% during the 1st quarter. Vanguard Group Inc. now owns 2,274,870 shares of the medical equipment provider’s stock worth $89,289,000 after acquiring an additional 105,008 shares in the last quarter. Columbia Wanger Asset Management LLC grew its stake in shares of Natus Medical by 243.6% during the 1st quarter. Columbia Wanger Asset Management LLC now owns 2,030,207 shares of the medical equipment provider’s stock worth $79,686,000 after acquiring an additional 1,439,382 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of Natus Medical by 105.7% during the 1st quarter. Wellington Management Group LLP now owns 1,795,094 shares of the medical equipment provider’s stock worth $70,457,000 after acquiring an additional 922,268 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of Natus Medical by 2.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,401,566 shares of the medical equipment provider’s stock worth $55,010,000 after acquiring an additional 38,125 shares in the last quarter. 92.65% of the stock is owned by institutional investors.
Shares of Natus Medical Incorporated (BABY) opened at 35.10 on Friday. The firm has a market cap of $1.14 billion, a P/E ratio of 60.83 and a beta of 0.96. Natus Medical Incorporated has a 12-month low of $31.65 and a 12-month high of $44.39. The stock has a 50 day moving average price of $33.95 and a 200 day moving average price of $36.10.
Natus Medical (NASDAQ:BABY) last announced its quarterly earnings results on Wednesday, July 26th. The medical equipment provider reported $0.34 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.33 by $0.01. Natus Medical had a return on equity of 12.09% and a net margin of 4.20%. The business had revenue of $122.20 million during the quarter, compared to the consensus estimate of $121.99 million. During the same quarter in the prior year, the company posted $0.39 earnings per share. Natus Medical’s revenue was up 27.3% compared to the same quarter last year. On average, equities analysts expect that Natus Medical Incorporated will post $1.70 earnings per share for the current year.
Several research firms have recently commented on BABY. BidaskClub downgraded Natus Medical from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. Zacks Investment Research raised Natus Medical from a “sell” rating to a “hold” rating in a report on Tuesday, June 27th. Three analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the stock. Natus Medical currently has a consensus rating of “Hold” and a consensus price target of $44.50.
ILLEGAL ACTIVITY NOTICE: This story was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another website, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this story can be read at https://www.thecerbatgem.com/2017/09/16/systematic-financial-management-lp-raises-stake-in-natus-medical-incorporated-baby.html.
In related news, Director Robert A. Gunst sold 4,400 shares of the company’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $35.17, for a total transaction of $154,748.00. Following the completion of the sale, the director now owns 50,850 shares in the company, valued at $1,788,394.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director William M. Moore sold 3,000 shares of the company’s stock in a transaction on Monday, August 14th. The stock was sold at an average price of $34.10, for a total value of $102,300.00. Following the sale, the director now owns 30,410 shares of the company’s stock, valued at approximately $1,036,981. The disclosure for this sale can be found here. Corporate insiders own 5.50% of the company’s stock.
About Natus Medical
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Want to see what other hedge funds are holding BABY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natus Medical Incorporated (NASDAQ:BABY).
Receive News & Stock Ratings for Natus Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Incorporated and related stocks with our FREE daily email newsletter.